|
Model Number RSINT30038X |
Device Problems
Entrapment of Device (1212); Inflation Problem (1310); Material Deformation (2976); Positioning Problem (3009)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 02/20/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
An attempt was made to use one resolute integrity coronary drug eluting stent to treat a lesion in the mid right coronary artery (rca).The device was inspected with no issues.Negative prep was performed with no issues.It was reported that the stent failed to be placed due to guide support, and inflation difficulties occurred.There were issues deploying the stent.When the stent was retrieved back into the guide the proximal edge struts were disrupted and the system was removed.The patient is alive with no injury.
|
|
Manufacturer Narrative
|
Additional information: the lesion was non-calcified, non-tortuous with 80% stenosis.Negative prep was not performed.The lesion was not pre-dilated.The device did not pass through a previously deployed stent.Resistance was not noted while advancing the device to the lesion.It was later reported that when the device was taken to the target lesion, before reaching the target, due to support issue the non- medtronic guide catheter and wire came out of the artery.An attempt was made to retrieve the stent back into the guide catheter, but it was not possible to retrieve the stent back into the guide catheter.Therefore, all the systems had to be pulled back.The same guide catheter and wire were used with a new stent, as the previous stent was disrupted and did not reach the target lesion.There was deformation to the proximal edge struts.There was no stent dislodgement.There were no issues deploying the stent and no inflation difficulties occurred, as no attempt was made to inflate the balloon, and no attempt was made to deploy the stent.Initial reporter phone number updated.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Manufacturer Narrative
|
The wire used was a non-medtronic device.Correction: annex a code.The guide catheter used was a non-medtronic device.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Manufacturer Narrative
|
Additional information: annex d codes added.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|